Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis

Lars Lundell(Karolinska Institutet), A. Walan(Linköping University), Ian Sutherland(AstraZeneca (Sweden)), Jan Gunnar Hatlebakk(Haukeland University Hospital), L. Wallin(Odense University Hospital), H. E. Myrvold(St Olav's University Hospital), Anna Malm(AstraZeneca (Sweden)), Pekka Miettinen(Kuopio University Hospital)

British journal of surgery

January 29, 2007

10.1002/bjs.5492

Cited by 171

Related Papers

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa

|Gastroenterology|2000|544

A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop1 1Members of the workshop composed a group of international experts in BE from gastroenterology, surgery, pathology, molecular biology, outcomes, and epidemiology. Conference chairman: Prateek Sharma; conference moderator: Kenneth McQuaid; group leaders: John Dent, M. Brian Fennerty, Richard Sampliner, Stuart Spechler; participants: Alan Cameron, Douglas Corley, Gary Falk, John Goldblum, John Hunter, Janusz Jankowski, Lars Lundell, Brian Reid, Nicholas Shaheen, Amnon Sonnenberg, Kenneth Wang, and Wilfred Weinstein.

|Gastroenterology|2004|526

Effect of Omeprazole and Ranitidine on Ulcer Healing and Relapse Rates in Patients with Benign Gastric Ulcer

|New England Journal of Medicine|1989|382

Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process

|Gastroenterology|2012|378

Cure of <i>Helicobacter pylori</i> infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial

|Gut|2003|220